Primer Dismenoreli Kadınların Menstrual Siklus Fazlarında Ağrı Algısının İncelenmesi

Göster/ Aç
Tarih
2025-02Yazar
Çelebi, Miray
Ambargo Süresi
Acik erisimÜst veri
Tüm öğe kaydını gösterÖzet
This study explored how pain (intensity, threshold, and tolerance)
varies across the menstrual cycle phases in individuals with primary dysmenorrhea
(PD) compared to those without, as well as whether the perceived pain is
catastrophized. A total of 50 literate female volunteers with regular menstrual cycles
who were capable of completing evaluation scales were included. Participants were
divided into two groups: the PD group (n = 25; age: 22.64 ± 2.63 years, height: 164.20
± 4.47 cm, weight: 59.68 ± 7.24 kg, Body Mass Index (BMI): 22.15 ± 2.78 kg/m²) and
the non-PD group (n = 25; age: 22.64 ± 2.53 years, height: 165.68 ± 5.73 cm, weight:
60.48 ± 8.76 kg, BMI: 22.06 ± 3.13 kg/m²). Physical, demographic, and menstrual
characteristics, along with medical histories, were recorded for all participants. Pain
intensity was assessed using the Visual Analog Scale (VAS), while attitudes toward
menstruation were evaluated with the Menstrual Attitude Questionnaire. Pain
thresholds and tolerance levels were measured using an algometer during the
menstrual (Day 1), follicular (Day 12), and luteal (Day 20) phases. Additionally, in the
PD group, the Pain Catastrophizing Scale, Coping Strategies Questionnaire, and Pain
Self-Efficacy Questionnaire were employed. The findings revealed significant
differences in pain threshold, tolerance, and VAS scores across the menstrual cycle
phases in the PD group (p < 0.001). Scores on the Menstrual Attitude Questionnaire
were significantly lower during the menstrual phase compared to other phases (p =
0.049), while no differences were observed between the follicular and luteal phases (p
> 0.05). Pain catastrophizing scores were highest during the menstrual phase, with a
marked reduction observed in the follicular and luteal phases (p < 0.001). Coping
strategies scores were low during the menstrual and follicular phases but significantly
increased in the luteal phase (p < 0.001). Pain self-efficacy scores were lowest during
the menstrual phase, showed notable improvement in the follicular phase, and peaked
during the luteal phase. In the non-PD group, significant differences in pain threshold
and tolerance were also noted across the cycle phases (p < 0.001). Comparisons
between PD and non-PD individuals revealed significant differences in pain threshold
and tolerance levels (p < 0.001), with similar trends observed across phases in both
groups. These results indicate that menstrual cycle phases have a significant impact on
pain perception and management, with these effects being more pronounced in
individuals with primary dysmenorrhea.